Q-omics provides the consensus-scored RNU6-359P profile across patient tissues and cancer cell-line models. RNU6-359P expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, RNU6-359P RNA expression shows 5,830 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LIHC, and STAD as cancer lineages where RNU6-359P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-359P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-359P survival associations across molecular data types. RNU6-359P RNA expression shows survival associations in the most cancer types (6). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-359P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	6	READ (72)	view →

This table ranks reproducible RNU6-359P RNA expression–survival associations across cancer types. High RNU6-359P expression shows unfavorable associations in LIHC, READ, KIRC, STAD, TGCT and ESCA. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LIHC as the clearest survival context for RNU6-359P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	II,III,IV	0.051	0.716	<.001	72	view →
READ	OS	Tertile	All	0.166	0.830	<.001	72	view →
KIRC	OS	Tertile	II,III,IV	0.578	0.809	.014	36	view →
STAD	OS	Tertile	All	0.443	0.745	.001	27	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →
ESCA	DFS	Tertile	All	0.148	0.673	.040	18	view →

Pink = unfavorable, green = favorable. all 6 lineages →

RNU6-359P-LIHC (OS)

Kaplan–Meier survival curve for RNU6-359P RNA expression in LIHC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-359P in patient tissues and cancer cell lines. In patient samples, RNU6-359P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,830	STAD (5659)	view →
RNA	4,605	ESCA (1459)	view →